
Browsing restrictions can be lifted for a fee.
Topco Scientific Co., Ltd. provides precision materials, processing equipment, and components for semiconductor and opto-electronic industries in Taiwan, China, and internationally. It also offers semiconductor related products, such as wafer and wafer processing materials; wafer carriers; thin films; photolithography materials; etching and furnace products, including quartz glass products, chemical, and special gases; CMP slurry products; package and testing related materials and equipment; and semiconductor equipment. In addition, the company offers LCD related equipment and materials; LED related photoelectric related products; solar materials comprising conductive paste for solar cells, quartz crucibles, SiC powder, coolants, diamond wires, chemicals, and special gases; and electronic materials. Further, it undertakes water treatment, clean room and electromechanical, and public construction projects; and solar power plant projects, as well as provides IC foundry services. The company was founded in 1990 and is headquartered in Taipei, Taiwan.
5434
崇越
-1.52%
(-0.02)
The most recent financial report for 崇越 (5434) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 5434's short-term business performance and financial health. For the latest updates on 5434's earnings releases, visit this page regularly.
According to historical valuation range analysis, 崇越 (5434)'s current price-to-earnings (P/E) ratio is 12.13, placing it in the Overvalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
According to the latest financial report, 崇越 (5434) reported an Operating Profit of 1.22B with an Operating Margin of 6.98% this period, representing a growth of 10.41% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, 崇越 (5434) announced revenue of 17.54B, with a Year-Over-Year growth rate of 14.13%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
At the end of the period, 崇越 (5434) held Total Cash and Cash Equivalents of 5.35B, accounting for 0.14 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, 崇越 (5434) achieved the “three margins increasing” benchmark, with a gross margin of 12.84%%, operating margin of 6.98%%, and net margin of 6.32%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 5434's profit trajectory and future growth potential.
According to the past four quarterly reports, 崇越 (5434)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 5.75. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
崇越 (5434)'s Free Cash Flow (FCF) for the period is -447.8M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 492.78% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.